Business
Terumo to acquire OrganOx Limited, a leading innovator in organ preservation devices, marking strategic entry into the organ transplantation-related sector
- Expanding opportunities for organ transplantation worldwide and contributing to the advancement of transplant medicine - OXFORD, United Kingdom and MADISON, N.J., Aug. 24, 2025 (GLOBE NEWSWIRE) -- Terumo Corporation (TSE: 4543, “Terumo”) today announced that Terumo has entered into a definitive agreement dated August 23, 2025, with OrganOx Limited (“OrganOx” or the “Company”), a leading innovator in organ preservation devices, and its shareholders to acquire all outstanding shares of OrganOx.
About this update from Terumo Corporation
[{"type":"image","alt":"ORGANOX LIMITED","displaySize":"","headline":null,"caption":"ORGANOX LIMITED","className":"","disableSlideshowImg":false,"size":{"original":{"width":218,"height":52,"url":"https://media.zenfs.com/en/globenewswire.com/ca252a38aed1b30c38ede554d96340d5"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/pzw2VZ0iQqwoRO0awZuBlg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTEwMDtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/ca252a38aed1b30c38ede554d96340d5","width":218,"height":52}},"lazy":false},{"type":"text","content":"- Expanding opportunities for organ transplantation worldwide and contributing to the advancement of transplant medicine -","length":122,"tagName":"p"},{"type":"text","content":"OXFORD, United Kingdom and MADISON, N.J., Aug. 24, 2025 (GLOBE NEWSWIRE) -- Terumo Corporation (TSE: 4543, “Terumo”) today announced that Terumo has entered into a definitive agreement dated August 23, 2025, with OrganOx Limited (“OrganOx” or the “Company”), a leading innovator in organ preservation devices, and its shareholders to acquire all outstanding shares of OrganOx. Upon completion of the transaction, OrganOx will become a wholly owned subsidiary of Terumo. The total transaction value is approximately USD $1.5 billion*1.","length":534,"tagName":"p"},{"type":"text","content":"Founded in 2008 by Professor Peter Friend and Professor Constantin Coussios as a spin-off from the University of Oxford, OrganOx is a pioneering medical technology company specializing in advanced organ preservation devices for Normothermic Machine Perfusion (NMP). NMP and other ex-vivo machine perfusion (EVMP) technologies can preserve organs longer by circulating oxygen and nutrient rich perfusate through the organ at near-body temperature. In addition, NMP devices enable real-time monitoring of organ condition during storage and transport. This aims to help prevent the transplantation of organs with impaired function—with the goal of improving transplant success rates—as well as leading to a more effective use of organs from marginal donors.","length":754,"tagName":"p"},{"type":"text","content":"The acquisition marks Terumo’s strategic entry into the organ transplantation-related sector—a field with significant unmet medical needs and strong growth potential. By combining Terumo’s long-standing expertise in designing medical devices and equipment with OrganOx’s a...